| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC1036 | bml-259 | Potent and selective inhibitor of Cdk5/p25, protecting large population of cells against non-A |
|
| DCC1037 | Bml277 Acid | Metabolite of BML277 which is a selective checkpoint kinase 2 inhibitor |
|
| DCC1038 | Bmp Activator B06 | Novel activator of BMP signaling, enhancing osteoblast differentiation, targeting HECT domain of ubiquitin ligase Smurf1, up-regulating the protein level of Smad1/5 |
|
| DCC1039 | Bmp Activator B75 | Novel activator of BMP signaling, enhancing osteoblast differentiation, targeting HECT domain of ubiquitin ligase Smurf1, up-regulating the protein level of Smad1/5 |
|
| DCC1040 | Bmppb-32 | Novel Highly Selective LRRK2 Inhibitor |
|
| DCC1041 | Bms-1016 | Novel PD-L1 Inhibitor |
|
| DCC1042 | Bms1018 | Novel PD-1/PD-L1 Inhibitor |
|
| DCC1043 | Bms-124110 | Novel potent, selective inhibitor of AAK1 (adaptor associated kinase 1), having the appropriate combination of solubility and charge required for microiontophoresis |
|
| DCC1044 | Bms-180048 Fumarate | 5HT1B/1D agonist |
|
| DCC1045 | bms-180448 | Novel K channel opener; Glyburide-Reversible Cardioprotective Agent with Minimal Vasodilator Activity |
|
| DCC1046 | Bms-181184 | Novel antifungal and fungicidal agent |
|
| DCC1047 | BMS-182874 Hydrochloride | Quantity (mg or Unit) Unit Price ($/mg or $/Unit) Final Price 100 $13.95 Total: $1,395.00 50 $16.12 Total: $806.00 25 $18.91 Total: $472.75 10 $22.32 Total: $223.20 5 $26.35 Total: $131.75 |
|
| DCC1048 | Bms184394 Featured | Novel selective inhibitor of RARγ |
|
| DCC1049 | Bms-187745 | Squalene synthase inhibitor |
|
| DCC1050 | bms-189532 | Retinoic acid receptor (RAR) pan-antagonist |
|
| DCC1051 | Bms-193885 | Novel and selective neuropeptide Y1 receptor antagonist |
|
| DCC1052 | Bms-199264 Hydrochloride | Novel potent inhibitor of the ATP hydrolase activity of mitochondrial F1F0 ATP synthase |
|
| DCC1053 | Bms-201620 | Potent and selective β3 full agonist |
|
| DCC1054 | Bms-243117 | Potent and selective p56(lck) inhibitor |
|
| DCC1055 | Bms-250685 | Selective ATP hydrolase inhibitor |
|
| DCC1056 | Bms-262084 | Potent and selective beta-lactam tryptase inhibitor, inhibiting factor XIa and producing antithrombotic efficacy with minimal bleeding time prolongation |
|
| DCC1057 | Bms-281384 | Highly potent and selective phosphodiesterase 5 (PDE 5) inhibitor |
|
| DCC1058 | Bms-286309 | Novel fluoro-substituted camptothecin, inducing topoisomerase I-mediated DNA breaks |
|
| DCC1059 | Bms-341 | Novel dissociated glucocorticoid receptor modulator |
|
| DCC1060 | Bms-351 | Novel Selective CYP17A1 Lyase Inhibitor |
|
| DCC1061 | Bms-422461 | Prodrug of the novel fluoro-substituted camptothecin analog, BMS-286309 |
|
| DCC1062 | Bms-488043 | Novel Inhibitor of human immunodeficiency virus type 1 (HIV-1) attachment |
|
| DCC1063 | Bms-538305 Tartrate | Potent and selective dipeptidyl peptidase IV (DPP-IV) inhibitor |
|
| DCC1064 | Bms-566394 | Novel, potent, exceptionally selective inhibitor of TNF-α Converting Enzyme (TACE) |
|
| DCC1065 | Bms-585248 | Novel Inhibitor of human immunodeficiency virus type 1 (HIV-1) attachment |
|
